Russell Investments Group, Ltd. Mustang Bio, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$1.66 - $2.64 $733,417 - $1.17 Million	-441,818 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$2.58 - $3.36 $1.14 Million - $1.48 Million	441,818 New	441,818 $1.19 Million
Q2 2021 Aug 04, 2021	SELL	$2.7 - $3.81 $392,971 - $554,526	-145,545 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$3.02 - $5.16 $192,186 - $328,372	-63,638 Reduced 30.42%	145,545 $482,000
Q4 2020 Feb 08, 2021	BUY	$2.66 - $4.18 $428,893 - $673,974	161,238 Added 336.3%	209,183 $791,000
Q3 2020 Nov 09, 2020	BUY	$3.01 - $3.88 $127,103 - $163,840	42,227 Added 738.49%	47,945 $150,000
Q2 2020 Aug 05, 2020	BUY	$2.33 - $4.6 $13,322 - $26,302	5,718 New	5,718 $18,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $24.2M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.